EHTH

EHTH
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $53.869M ▼ | $95.394M ▲ | $-31.691M ▼ | -58.83% ▼ | $-1.46 ▼ | $-37.406M ▼ |
| Q2-2025 | $60.782M ▼ | $83.826M ▼ | $-17.398M ▼ | -28.624% ▼ | $-0.98 ▼ | $-18.233M ▼ |
| Q1-2025 | $113.119M ▼ | $108.321M ▼ | $1.95M ▼ | 1.724% ▼ | $-0.33 ▼ | $10.308M ▼ |
| Q4-2024 | $315.181M ▲ | $202.541M ▲ | $97.482M ▲ | 30.929% ▲ | $2.88 ▲ | $116.942M ▲ |
| Q3-2024 | $58.409M | $101.608M | $-42.473M | -72.717% | $-1.83 | $-37.673M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $75.301M ▼ | $1.047B ▼ | $162.946M ▼ | $884.469M ▼ |
| Q2-2025 | $105.2M ▼ | $1.08B ▼ | $165.878M ▼ | $913.833M ▼ |
| Q1-2025 | $155.587M ▲ | $1.137B ▼ | $207.554M ▼ | $929.608M ▲ |
| Q4-2024 | $82.24M ▼ | $1.155B ▲ | $566.997M ▲ | $588.428M ▼ |
| Q3-2024 | $117.782M | $1.002B | $175.52M | $826.471M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-31.691M ▼ | $-25.313M ▲ | $23.695M ▲ | $-1.276M ▲ | $-2.831M ▲ | $-28.936M ▲ |
| Q2-2025 | $-17.398M ▼ | $-41.204M ▼ | $-10.119M ▼ | $-3.844M ▼ | $-55.172M ▼ | $-47.047M ▼ |
| Q1-2025 | $1.95M ▼ | $77.121M ▲ | $5.472M ▼ | $-699K ▲ | $81.895M ▲ | $77.121M ▲ |
| Q4-2024 | $97.482M ▲ | $-27.662M ▲ | $7.992M ▲ | $-4.983M ▼ | $-24.835M ▲ | $-30.985M ▲ |
| Q3-2024 | $-42.473M | $-29.283M | $-32.678M | $-450K | $-62.312M | $-33.472M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Ancillaries | $10.00M ▲ | $10.00M ▲ | $0 ▼ | $0 ▲ |
Commission | $330.00M ▲ | $100.00M ▼ | $50.00M ▼ | $50.00M ▲ |
Commission Bonus | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Commission Members Approved In Prior Periods | $0 ▲ | $0 ▲ | $20.00M ▲ | $10.00M ▼ |
Individual and Family | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Medicare | $310.00M ▲ | $90.00M ▼ | $50.00M ▼ | $40.00M ▼ |
Product and Service Other | $50.00M ▲ | $10.00M ▼ | $10.00M ▲ | $10.00M ▲ |
Small Business | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, eHealth looks like a business with a strong strategic position in a specialized corner of the insurance market but with a financial profile still in transition. The income statement shows movement from meaningful losses toward modest profitability, while the balance sheet remains reasonably sturdy with limited leverage. However, persistent negative cash flow underlines that the turnaround is not yet complete. Its competitive edge is built on technology, a broad carrier network, and a hybrid human‑digital service model, supported by ongoing investment in AI and data. Future performance will hinge on whether these innovations can translate into consistently profitable growth and positive cash generation amid competitive and regulatory pressures.
NEWS
November 12, 2025 · 9:00 AM UTC
eHealth Advances its AI Strategy with Expanded Voice Agent Capabilities
Read more
November 6, 2025 · 9:00 AM UTC
Health Insurance Open Enrollment: Most Americans are Satisfied with Coverage, But 73% Delay Care Due to Costs
Read more
November 5, 2025 · 4:15 PM UTC
eHealth, Inc. Announces Third Quarter 2025 Results
Read more
October 30, 2025 · 4:15 PM UTC
eHealth, Inc. to Hold Third Quarter 2025 Earnings Call on November 5 at 5:00 p.m. Eastern Time
Read more
October 7, 2025 · 4:30 PM UTC
eHealth Announces Extension of Blue Torch Term Loan
Read more
About eHealth, Inc.
https://www.ehealthinsurance.comeHealth, Inc. operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Individual, Family and Small Business.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $53.869M ▼ | $95.394M ▲ | $-31.691M ▼ | -58.83% ▼ | $-1.46 ▼ | $-37.406M ▼ |
| Q2-2025 | $60.782M ▼ | $83.826M ▼ | $-17.398M ▼ | -28.624% ▼ | $-0.98 ▼ | $-18.233M ▼ |
| Q1-2025 | $113.119M ▼ | $108.321M ▼ | $1.95M ▼ | 1.724% ▼ | $-0.33 ▼ | $10.308M ▼ |
| Q4-2024 | $315.181M ▲ | $202.541M ▲ | $97.482M ▲ | 30.929% ▲ | $2.88 ▲ | $116.942M ▲ |
| Q3-2024 | $58.409M | $101.608M | $-42.473M | -72.717% | $-1.83 | $-37.673M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $75.301M ▼ | $1.047B ▼ | $162.946M ▼ | $884.469M ▼ |
| Q2-2025 | $105.2M ▼ | $1.08B ▼ | $165.878M ▼ | $913.833M ▼ |
| Q1-2025 | $155.587M ▲ | $1.137B ▼ | $207.554M ▼ | $929.608M ▲ |
| Q4-2024 | $82.24M ▼ | $1.155B ▲ | $566.997M ▲ | $588.428M ▼ |
| Q3-2024 | $117.782M | $1.002B | $175.52M | $826.471M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-31.691M ▼ | $-25.313M ▲ | $23.695M ▲ | $-1.276M ▲ | $-2.831M ▲ | $-28.936M ▲ |
| Q2-2025 | $-17.398M ▼ | $-41.204M ▼ | $-10.119M ▼ | $-3.844M ▼ | $-55.172M ▼ | $-47.047M ▼ |
| Q1-2025 | $1.95M ▼ | $77.121M ▲ | $5.472M ▼ | $-699K ▲ | $81.895M ▲ | $77.121M ▲ |
| Q4-2024 | $97.482M ▲ | $-27.662M ▲ | $7.992M ▲ | $-4.983M ▼ | $-24.835M ▲ | $-30.985M ▲ |
| Q3-2024 | $-42.473M | $-29.283M | $-32.678M | $-450K | $-62.312M | $-33.472M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Ancillaries | $10.00M ▲ | $10.00M ▲ | $0 ▼ | $0 ▲ |
Commission | $330.00M ▲ | $100.00M ▼ | $50.00M ▼ | $50.00M ▲ |
Commission Bonus | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Commission Members Approved In Prior Periods | $0 ▲ | $0 ▲ | $20.00M ▲ | $10.00M ▼ |
Individual and Family | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Medicare | $310.00M ▲ | $90.00M ▼ | $50.00M ▼ | $40.00M ▼ |
Product and Service Other | $50.00M ▲ | $10.00M ▼ | $10.00M ▲ | $10.00M ▲ |
Small Business | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, eHealth looks like a business with a strong strategic position in a specialized corner of the insurance market but with a financial profile still in transition. The income statement shows movement from meaningful losses toward modest profitability, while the balance sheet remains reasonably sturdy with limited leverage. However, persistent negative cash flow underlines that the turnaround is not yet complete. Its competitive edge is built on technology, a broad carrier network, and a hybrid human‑digital service model, supported by ongoing investment in AI and data. Future performance will hinge on whether these innovations can translate into consistently profitable growth and positive cash generation amid competitive and regulatory pressures.
NEWS
November 12, 2025 · 9:00 AM UTC
eHealth Advances its AI Strategy with Expanded Voice Agent Capabilities
Read more
November 6, 2025 · 9:00 AM UTC
Health Insurance Open Enrollment: Most Americans are Satisfied with Coverage, But 73% Delay Care Due to Costs
Read more
November 5, 2025 · 4:15 PM UTC
eHealth, Inc. Announces Third Quarter 2025 Results
Read more
October 30, 2025 · 4:15 PM UTC
eHealth, Inc. to Hold Third Quarter 2025 Earnings Call on November 5 at 5:00 p.m. Eastern Time
Read more
October 7, 2025 · 4:30 PM UTC
eHealth Announces Extension of Blue Torch Term Loan
Read more

CEO
Francis Samuel Soistman Jr.
Compensation Summary
(Year 2024)

CEO
Francis Samuel Soistman Jr.
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : A
Most Recent Analyst Grades
Grade Summary
Price Target
Institutional Ownership

BLACKROCK, INC.
2.797M Shares
$11.412M

8 KNOTS MANAGEMENT, LLC
2.332M Shares
$9.515M

NANTAHALA CAPITAL MANAGEMENT, LLC
1.761M Shares
$7.187M

PALO ALTO INVESTORS LP
1.545M Shares
$6.302M

VANGUARD GROUP INC
1.526M Shares
$6.226M

BLACKROCK FUND ADVISORS
1.427M Shares
$5.824M

FINDELL CAPITAL MANAGEMENT LLC
1.225M Shares
$4.998M

BLACKROCK INC.
1.122M Shares
$4.579M

DIMENSIONAL FUND ADVISORS LP
1.05M Shares
$4.284M

CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.
758.78K Shares
$3.096M

GEODE CAPITAL MANAGEMENT, LLC
718.227K Shares
$2.93M

DSC ADVISORS, L.P.
600K Shares
$2.448M

D. E. SHAW & CO., INC.
596.578K Shares
$2.434M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
467.668K Shares
$1.908M

REDWOOD CAPITAL MANAGEMENT, LLC
467.395K Shares
$1.907M

ARISTOTLE CAPITAL BOSTON, LLC
460.734K Shares
$1.88M

UBS GROUP AG
397.722K Shares
$1.623M

MACKENZIE FINANCIAL CORP
396.979K Shares
$1.62M

STATE STREET CORP
385.331K Shares
$1.572M

ACADIAN ASSET MANAGEMENT LLC
358.435K Shares
$1.462M
Summary
Only Showing The Top 20



